JP2002525266A5 - - Google Patents

Download PDF

Info

Publication number
JP2002525266A5
JP2002525266A5 JP2000569816A JP2000569816A JP2002525266A5 JP 2002525266 A5 JP2002525266 A5 JP 2002525266A5 JP 2000569816 A JP2000569816 A JP 2000569816A JP 2000569816 A JP2000569816 A JP 2000569816A JP 2002525266 A5 JP2002525266 A5 JP 2002525266A5
Authority
JP
Japan
Prior art keywords
use according
antimicrobial
combination
drug
gastric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000569816A
Other languages
English (en)
Japanese (ja)
Other versions
JP4981208B2 (ja
JP2002525266A (ja
Filing date
Publication date
Priority claimed from US09/316,115 external-priority patent/US6117868A/en
Application filed filed Critical
Publication of JP2002525266A publication Critical patent/JP2002525266A/ja
Publication of JP2002525266A5 publication Critical patent/JP2002525266A5/ja
Application granted granted Critical
Publication of JP4981208B2 publication Critical patent/JP4981208B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000569816A 1998-09-16 1999-09-13 感染性潰瘍又は胃炎に対するタウロリジン及び／又はタウルルタム Expired - Fee Related JP4981208B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15445198A 1998-09-16 1998-09-16
US09/154,451 1998-09-16
US09/316,115 1999-05-20
US09/316,115 US6117868A (en) 1998-09-16 1999-05-20 Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
PCT/GB1999/003030 WO2000015232A1 (en) 1998-09-16 1999-09-13 Taurolidine and/or taurultam against infectious ulcer or gastritis

Publications (3)

Publication Number Publication Date
JP2002525266A JP2002525266A (ja) 2002-08-13
JP2002525266A5 true JP2002525266A5 (https=) 2006-11-02
JP4981208B2 JP4981208B2 (ja) 2012-07-18

Family

ID=26851461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000569816A Expired - Fee Related JP4981208B2 (ja) 1998-09-16 1999-09-13 感染性潰瘍又は胃炎に対するタウロリジン及び／又はタウルルタム

Country Status (8)

Country Link
US (1) US6117868A (https=)
EP (1) EP1112074B1 (https=)
JP (1) JP4981208B2 (https=)
CA (1) CA2344308C (https=)
DE (1) DE69916629T2 (https=)
ES (1) ES2219061T3 (https=)
RU (1) RU2227033C2 (https=)
WO (1) WO2000015232A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US8304390B2 (en) * 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US8030301B2 (en) * 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7345039B2 (en) * 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US7892530B2 (en) * 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
JP2001122777A (ja) * 1999-10-27 2001-05-08 Nagase & Co Ltd 抗潰瘍剤
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
JP5027369B2 (ja) * 1999-12-06 2012-09-19 ガイストリッヒ ファーマ アーゲー 腫瘍を治療する方法
FR2803206A1 (fr) * 1999-12-30 2001-07-06 Aventis Pharma Sa Composition comprenant des acides nucleiques, preparation et utilisation
US6365198B1 (en) * 2001-01-28 2002-04-02 Gulf Pharmaceutical Industries Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids
EP1450814B1 (en) 2001-10-01 2016-11-30 Geistlich Pharma AG Methods of inhibiting metastases
FI20021819A0 (fi) * 2002-10-14 2002-10-14 Pekka Untamo Heino Valmiste alkoholin metabolian tehostamiseksi
RU2265437C2 (ru) * 2003-07-02 2005-12-10 Суханов Александр Владимирович Способ лечения заболеваний желудка и двенадцатиперстной кишки, вызванных helicobacter pylori
US20080177217A1 (en) * 2004-05-14 2008-07-24 Hans-Dietrich Polaschegg Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation
PT1967195E (pt) * 2006-12-20 2011-12-22 Kyowa Chem Ind Co Ltd Antiácido
RU2410100C2 (ru) 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
CA2790708A1 (en) * 2010-02-24 2011-09-01 Emisphere Technologies, Inc. Oral b12 therapy
EP2601947A1 (en) * 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
WO2013190355A1 (en) * 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents
KR20180105115A (ko) * 2015-10-07 2018-09-27 코르메딕스, 인코포레이티드 타우로리딘의 피부-침투성 제제
CN117159461A (zh) * 2023-07-26 2023-12-05 合肥远志医药科技开发有限公司 一种铝碳酸镁混悬液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3533612A1 (de) * 1985-09-20 1987-04-02 Johannes Reinmueller Neuartige verwendung von taurolin
GB8617482D0 (en) * 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
EP0406248B1 (de) * 1989-01-19 1994-06-08 Alfred Schmidt Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
TW276996B (https=) * 1992-04-24 1996-06-01 Astra Ab
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
JPH09121890A (ja) * 1995-10-30 1997-05-13 Mitsubishi Kagaku B C L:Kk ヘリコバクター属細菌の検出方法
SE507682C2 (sv) * 1996-03-29 1998-07-06 Marcin Krotkiewski Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
JPH1017471A (ja) * 1996-07-04 1998-01-20 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物系併用医薬
JP3677376B2 (ja) * 1996-08-13 2005-07-27 武田薬品工業株式会社 医薬
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections

Similar Documents

Publication Publication Date Title
JP2002525266A5 (https=)
RU2143899C1 (ru) Фармацевтическая композиция, способ ее получения и способ лечения
US7815940B2 (en) Gastric acid secretion inhibiting composition
US11135172B2 (en) Rifabutin-based compositions and methods for treating Helicobacter pylori infection
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
JP2013539790A (ja) メマンチンを含む鎮咳組成物
IL136827A (en) Pharmaceutical dosage form for oral administration with prolonged release
RU2001107149A (ru) Тауролидин и/или таурултам против инфекционной язвенной болезни или инфекционного гастрита
WO2002098352A3 (en) PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
EP1898925A2 (en) Method for the treatment of acne
US9370481B2 (en) Compositions and methods for inhibiting gastric acid secretion
CA2524979A1 (en) Solid dosage form comprising (s)-pantoprazole magnesium salt
EP2364145A1 (en) Dosage forms for the rapid and sustained elevation of gastric ph
WO2007125397A2 (en) Compositions and methods for inhibiting gastric acidity using endoperoxide bridge-containing compounds
KR101153571B1 (ko) 테나토프라졸 및 히스타민 ｈ2-수용체 길항제를 배합한제약 조성물
US6162792A (en) Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
CA3268565A1 (en) Compositions and methods of prevention and treatment of radiation skin injury
Osborne The treatment of Helicobacter pylori infection in the management of peptic ulcer disease
Gheng et al. Helicobacter pyloriand NSAID-Associated Ulcers.
RU97111830A (ru) Соединения для ингибирования секреции желудочной кислоты
MXPA96004986A (es) Utilizacion de espiramicina en transtornos gastrointestinales causados por h. pylori
WO2017090902A1 (ko) 구강 지혈 및 상처 보호 필름
RU99127466A (ru) Сферические микрогранулы с контролируемым высвобождением с задержкой в желудке для улучшенной доставки лекарственных препаратов
CA2563162A1 (en) Dosage form containing pantoprazole as active ingredient
MXPA00005896A (en) Oral pharmaceutical extended release dosage form